ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,868, issued on Jan. 20, was assigned to Pfizer Inc. (New York) and Children's Medical Center Corp. (Boston).
"CD1a antibodies and uses thereof" was invented by Florian Winau (Boston), Oleg V. Kovalenko (Arlington, Mass.), Chew Shun Chang (Quincy, Mass.), Di Wu (Lexington, Mass.), Nicholas Andrew Marze (Quincy, Mass.) and Shian-Huey Chiang (Cary, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof."
The patent was...